In the United States, the company Warrior Labz SARMS received a warning letter from the Food and Drug Administration (FDA) last summer for selling Mercks experimental drug, MK-677
Presented for research literature review only Imai S et al
Theres been no groundswell from our members about challenging these items, perhaps because they dont meet the criteria under 503A. Under Section 503A of the Food, Drug & Cosmetic Act, an eligible bulk drug substance for compounding must be a component of an FDA-approved drug, must have a USP or NF monograph, or must appear on FDAs 503A Bulks List or Interim Bulks List Category 1
Not intended for human consumption or therapeutic use of any kind.
A unique super-charged, boosted MSM supplement to boost collagen, keratin and glutathione production to support skin and joint health, and the immune system